427 related articles for article (PubMed ID: 35139812)
21. Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial.
Glassman AR; Beaulieu WT; Maguire MG; Antoszyk AN; Chow CC; Elman MJ; Jampol LM; Salehi-Had H; Sun JK;
JAMA Ophthalmol; 2021 Jul; 139(7):725-733. PubMed ID: 33956075
[TBL] [Abstract][Full Text] [Related]
22. Prospective Comparison of Surgery Outcome Between Preoperative and Intraoperative Intravitreal Injection of Ranibizumab for Vitrectomy in Proliferative Diabetic Retinopathy Patients.
Li S; Tang J; Han X; Wang Z; Zhang L; Zhao M; Qu J
Ophthalmol Ther; 2022 Oct; 11(5):1833-1845. PubMed ID: 35904708
[TBL] [Abstract][Full Text] [Related]
23. Intravitreal Aflibercept injection with Panretinal photocoagulation versus early Vitrectomy for diabetic vitreous hemorrhage: randomized clinical trial.
Abd Elhamid AH; Mohamed AAEA; Khattab AM
BMC Ophthalmol; 2020 Apr; 20(1):130. PubMed ID: 32252674
[TBL] [Abstract][Full Text] [Related]
24. Intravitreal Conbercept Injection as an Adjuvant in Vitrectomy with Silicone Oil Infusion for Severe Proliferative Diabetic Retinopathy.
Gao S; Lin Z; Chen Y; Xu J; Zhang Q; Chen J; Shen X
J Ocul Pharmacol Ther; 2020 Jun; 36(5):304-310. PubMed ID: 32186940
[No Abstract] [Full Text] [Related]
25. Evaluation of Intravitreal Ranibizumab on the Surgical Outcome for Diabetic Retinopathy With Tractional Retinal Detachment.
Dong F; Yu C; Ding H; Shen L; Lou D
Medicine (Baltimore); 2016 Feb; 95(8):e2731. PubMed ID: 26937902
[TBL] [Abstract][Full Text] [Related]
26. Intraocular pharmacokinetics of anti-vascular endothelial growth factor agents by intraoperative subretinal versus intravitreal injection in silicone oil-filled eyes of proliferative diabetic retinopathy: a randomized controlled pilot study.
Yao TT; Yang Y; Jin XL; Wang YX; Zhou YL; Xu AJ; He FL; Wang ZY
Acta Ophthalmol; 2020 Nov; 98(7):e795-e800. PubMed ID: 32114709
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness and Safety of Coadministration of Intravitreal Dexamethasone Implant and Silicone Oil Endotamponade for Proliferative Diabetic Retinopathy with Tractional Diabetic Macular Edema.
Altun A; Kanar HS; Aki SF; Arsan A; Hacisalihoglu A
J Ocul Pharmacol Ther; 2021 Mar; 37(2):131-137. PubMed ID: 33325793
[No Abstract] [Full Text] [Related]
28. Intravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy.
Yang CS; Hung KC; Huang YM; Hsu WM
J Ocul Pharmacol Ther; 2013; 29(6):550-5. PubMed ID: 23495932
[TBL] [Abstract][Full Text] [Related]
29. VEGF-A gene polymorphisms and responses to intravitreal ranibizumab treatment in patients with diabetic macular edema.
Tetikoğlu M; Yüksel Z; Aktas S; Sağdik HM; Özcura F
Int Ophthalmol; 2018 Dec; 38(6):2381-2388. PubMed ID: 29030794
[TBL] [Abstract][Full Text] [Related]
30. Intravitreal ranibizumab versus vitrectomy for recurrent vitreous haemorrhage after pars plana vitrectomy for proliferative diabetic retinopathy: a prospective study.
Chatziralli I; Dimitriou E; Theodossiadis G; Bourouki E; Bagli E; Kitsos G; Theodossiadis P
Int Ophthalmol; 2020 Apr; 40(4):841-847. PubMed ID: 31788713
[TBL] [Abstract][Full Text] [Related]
31. Angiofibrotic response to vascular endothelial growth factor inhibition in diabetic retinal detachment: report no. 1.
Sohn EH; He S; Kim LA; Salehi-Had H; Javaheri M; Spee C; Dustin L; Hinton DR; Eliott D
Arch Ophthalmol; 2012 Sep; 130(9):1127-34. PubMed ID: 22965588
[TBL] [Abstract][Full Text] [Related]
32. Early vitreous hemorrhage after vitrectomy with preoperative intravitreal bevacizumab for proliferative diabetic retinopathy.
Sato T; Morita S; Bando H; Sato S; Ikeda T; Emi K
Middle East Afr J Ophthalmol; 2013; 20(1):51-5. PubMed ID: 23580852
[TBL] [Abstract][Full Text] [Related]
33. INTRAVITREAL CONBERCEPT (KH902) FOR SURGICAL TREATMENT OF SEVERE PROLIFERATIVE DIABETIC RETINOPATHY.
Su L; Ren X; Wei H; Zhao L; Zhang X; Liu J; Su C; Tan L; Li X
Retina; 2016 May; 36(5):938-43. PubMed ID: 26630313
[TBL] [Abstract][Full Text] [Related]
34. The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study.
Jiang T; Gu J; Zhang P; Chen W; Chang Q
BMC Ophthalmol; 2020 Feb; 20(1):43. PubMed ID: 32013913
[TBL] [Abstract][Full Text] [Related]
35. Effect of intravitreal bevacizumab on serum, aqueous, and vitreous humor levels of erythropoietin in patients with proliferative diabetic retinopathy.
Cancarini A; Costagliola C; Dell'omo R; Romano M; Morescalchi F; Agnifili L; Ruggeri G; Semeraro F
Minerva Endocrinol; 2014 Dec; 39(4):305-11. PubMed ID: 25371057
[TBL] [Abstract][Full Text] [Related]
36. Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial.
Li S; Guo L; Zhou P; Tang J; Wang Z; Zhang L; Zhao M; Qu J
Eye Vis (Lond); 2022 Dec; 9(1):44. PubMed ID: 36451252
[TBL] [Abstract][Full Text] [Related]
37. Cost Evaluation of Early Vitrectomy versus Panretinal Photocoagulation and Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy.
Lin J; Chang JS; Yannuzzi NA; Smiddy WE
Ophthalmology; 2018 Sep; 125(9):1393-1400. PubMed ID: 29606379
[TBL] [Abstract][Full Text] [Related]
38. Intravitreal ranibizumab alone or in combination with panretinal photocoagulation for the treatment of proliferative diabetic retinopathy with coexistent macular edema: long-term outcomes of a prospective study.
Chatziralli I; Dimitriou E; Theodossiadis G; Kazantzis D; Theodossiadis P
Acta Diabetol; 2020 Oct; 57(10):1219-1225. PubMed ID: 32472172
[TBL] [Abstract][Full Text] [Related]
39. Intravitreal ranibizumab for persistent diabetic vitreous haemorrhage: a randomised, double-masked, placebo-controlled feasibility study.
Petrarca R; Soare C; Wong R; Desai R; Neffendorf J; Simpson A; Jackson TL
Acta Ophthalmol; 2020 Dec; 98(8):e960-e967. PubMed ID: 31674134
[TBL] [Abstract][Full Text] [Related]
40. Predictors of visual outcome after pars plana vitrectomy secondary to proliferative diabetic retinopathy.
Nisic F; Gadzo AP; Fajkic A; Nisic A; Miokovic AP; Damjanovic G; Begic E; Beslic N; Lepara O
Rom J Ophthalmol; 2023; 67(3):283-288. PubMed ID: 37876512
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
